Rebekah Mathews
Physician Assistant · Anderson, INNPI 1700228319
Payments from drug & device makers
Across 215 payments — averaging $18.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novartis$829
- E.r. Squibb & Sons, L.L.C.$401
- Johnson & Johnson$396
- Pfizer$395
- Boehringer Ingelheim$275
- Novo Nordisk$182
- plus $1K from 19 others
What the payments were for
- Food & beverage$3,918100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novartis | 41 | $829 |
| E.r. Squibb & Sons, L.L.C. | 27 | $401 |
| Johnson & Johnson | 23 | $396 |
| Pfizer | 25 | $395 |
| Boehringer Ingelheim | 12 | $275 |
| Novo Nordisk | 8 | $182 |
| Bayer | 9 | $172 |
| AstraZeneca | 9 | $161 |
| Abbott | 7 | $158 |
| Lexicon Pharmaceuticals, Inc. | 9 | $136 |
| Kiniksa Pharmaceuticals International, PLC | 7 | $126 |
| Actelion Pharmaceuticals US, Inc. | 7 | $100 |
| Amgen | 6 | $100 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 7 | $94 |
| Boston Scientific | 1 | $59 |
| Edwards Lifesciences | 2 | $53 |
| Amarin Pharma, Inc. | 2 | $44 |
| Merck | 3 | $43 |
| Sanofi-aventis U.S. LLC | 2 | $40 |
| Daiichi Sankyo Inc. | 2 | $38 |
| Scpharmaceuticals Inc. | 2 | $30 |
| Alnylam Pharmaceuticals Inc. | 1 | $25 |
| Altathera Pharmaceuticals LLC | 1 | $20 |
| Amryt Pharma Holdings Ltd | 1 | $20 |
| Regeneron Healthcare Solutions, Inc. | 1 | $19 |
How this compares
$3,918 in reported general payments places this provider in the 90th percentile of 1,955 physician assistant providers in Indiana.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 45 | $36,170 |
| BrilintaTicagrelor | 44 | $20,032 |
| EntrestoSacubitril/Valsartan | 13 | $12,138 |
| Metoprolol Succinate | 56 | $595 |
| Torsemide | 25 | $396 |
| Amiodarone Hcl | 22 | $346 |
| ClopidogrelClopidogrel Bisulfate | 36 | $273 |
| Atorvastatin Calcium | 32 | $262 |
| Potassium Chloride | 17 | $193 |
| Carvedilol | 17 | $183 |
| Furosemide | 27 | $67 |
| Nitroglycerin | 13 | $66 |
| Spironolactone | 15 | $64 |
| Rosuvastatin Calcium | 11 | $55 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $395 | $36,17045 claims |
| AstraZenecaBrilinta | $161 | $20,03244 claims |
| NovartisEntresto | $829 | $12,13813 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 1,955 physician assistant providers in Indiana.
Other physician assistant in Anderson
- Kristen GumpfCarmel$142K
- Andrew NordIndianapolis$47K
- Qun Ming ZhangIndianapolis$28K
- Lauren HoweMunster$28K
- A FergusonFort Wayne$22K
- Jacquelyn BeemerFort Wayne$21K
- Lindsay YoderIndianapolis$21K
- Eryn GormanClinton$18K
- Audrey HewittBloomington$17K
- Mackenzie LawsonIndianapolis$15K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.